The DOI matches its Crossref record.
Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Open accessAbstract
BACKGROUND: The INTERCEPT Blood System, a photochemical treatment (PCT) process, has been developed to inactivate pathogens in platelet concen‐trates. These studies evaluated the efficacy of PCT to inactivate pathogens in plasma and the effect of PCT on plasma function. STUDY DESIGN AND METHODS: Jumbo (600 mL) plasma units were inoculated with high titers of test pathogens and treated with 150 µmol per L amotosalen and 3 J per cm 2 long‐wavelength ultraviolet light. The viability of each pathogen before and after treatment was measured with biological assays. Plasma function was evaluated through measurement of coagulation factors and antithrombotic protein activities. RESULTS: The levels of inactivation expressed as log‐reduction were as follows: cell‐free human immunodeficiency virus‐1 (HIV‐1), greater than 6.8; cell‐associated HIV‐1, greater than 6.4; human T‐lymphotropic virus‐I (HTLV‐I), 4.5; HTLV‐II, greater than 5.7; hepatitis B virus (HBV) and hepatitis C virus, greater than 4.5; duck HBV, 4.4 to 4.5; bovine viral diarrhea virus, 6.0; severe acute respiratory syndrome coronavirus, 5.5; West Nile virus, 6.8; bluetongue virus, 5.1; human adenovirus 5, 6.8; Klebsiella pneumoniae, greater than 7.4; Staphylococcus epidermidis and Yersinia enterocolitica, greater than 7.3; Treponema pallidum, greater than 5.9; Borrelia burgdorferi, greater than 10.6; Plasmodium falciparum, 6.9; Trypanosoma cruzi, greater than 5.0; and Babesia microti, greater than 5.3. Retention of coagulation factor activity after PCT was expressed as the proportion of pretreatment (baseline) activity. Retention was 72 to 73 percent of baseline fibrinogen and Factor (F)VIII activity and 78 to 98 percent for FII, FV, FVII, F IX, FX, FXI, FXIII, protein C, protein S, antithrombin, and α2‐antiplasmin. CONCLUSION: PCT of plasma inactivated high levels of a wide range of pathogens while maintaining adequate coagulation function. PCT has the potential to reduce the risk of transfusion‐transmitted diseases in patients requiring plasma transfusion support.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Emerging infectious disease agents and their potential threat to transfusion safety
Stramer, S. L., Hollinger, F. B., Katz, L. M., Kleinman, S., Metzel, P. S., Gregory, K. R., & Dodd, R. Y. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02279.x · Cited by 427
Hepatitis-E-Virus: Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit
Gesundheit, M. D. A. B. D. B. F. (2015) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-014-2103-4 · Cited by 374
Human Immunodeficiency Virus (HIV)
German Advisory Committee Blood (Arbeitskreis Blut), S. ‘. O. P. T. B. B. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000445852 · Cited by 355
Liu, W., Cimino, G. D., Corash, L., & Lin, L. (2011) · Transfusion · doi:10.1111/j.1537-2995.2010.02786.x · Cited by 12
Self-citation
Metadata
- Authors
- Singh, Y., Sawyer, L. S., Pinkoski, L. S., Dupuis, K. W., Hsu, J. C., Lin, L., & Corash, L.
- Venue
- Transfusion
- Publisher
- Wiley
- Published
- 2006-06-26
- Volume
- 46
- Issue
- 7
- Pages
- 1168-1177
- ISSN
- 0041-1132 (ISSN-L)
- 1537-2995
- OpenAlex
- W1968721502
- Cited by
- 164
- References
- 0
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation function. https://app.cochat.ai/papers/10.1111/j.1537-2995.2006.00867.x
- The paper
- Singh, Y., Sawyer, L. S., Pinkoski, L. S., Dupuis, K. W., Hsu, J. C., Lin, L., & Corash, L. (2006). Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion. https://doi.org/10.1111/j.1537-2995.2006.00867.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.